esmolol

potassium calcium-activated channel subfamily M regulatory beta subunit 1 ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31514219 [The Role of Ultrarapid Acting Betablocker Esmolol and Landiolol in Critically Ill Patients]. 2019 Sep 1
2 29665297 Esmolol acutely alters oxygen supply-demand balance in exercising muscles of healthy humans. 2018 Apr 1
3 28035016 Esmolol infusion versus propranolol infusion: effects on heart rate and blood pressure in healthy volunteers. 2017 Mar 1 2
4 27451411 Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions. 2016 Oct 2
5 26121122 Beta-blocker use in severe sepsis and septic shock: a systematic review. 2015 1
6 23902616 [Effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients]. 2013 Apr 23 1
7 19122550 Landiolol, a new ultra-short-acting beta1-blocker, reduces anaesthetic requirement during sevoflurane/N(2)O/fentanyl anaesthesia in surgical patients. 2009 Jan 1
8 19150530 Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. 2009 Jan-Feb 1
9 16215384 Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. 2005 Oct 1
10 12197593 Esmolol protects the myocardium and facilitates direct version intracardiac operation with a beating heart. 2002 Aug 1
11 12460877 Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance. 2002 Dec 3 1
12 12565117 The use of cardioselective beta-blockers in a patient with idiopathic hypertrophic subaortic stenosis and chronic obstructive pulmonary disease. 2002 Dec 1
13 11602813 Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol. 2001 Nov 1
14 7502643 Anesthetic management of the cocaine abuse patient. 1995 Oct 1
15 7957532 Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties. 1994 2
16 1688693 Treatment of caffeine toxicity with esmolol. 1990 Jan 1